Experience with refractory vitamin D-resistant rickets and non-17α alkyl testosterone derivative anabolic agent

Therapy

Volumn 2, Issue 1, 2005, Pages 91-94

  Al Mosawi, Aamir Jalal ^a  

^a AL NAHRAIN UNIVERSITY   (Iraq)

Author keywords

Nandrolone; Refractory rickets; Tubular defect; Vitamin D

Indexed keywords

ALFACALCIDOL; ALKALI; ANABOLIC AGENT; NANDROLONE DECANOATE; PHOSPHATE; POTASSIUM; VITAMIN D;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BONE AGE; BONE BOWING; BONE GROWTH; CASE REPORT; CHILD; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; FEMALE; HEALING; HUMAN; KIDNEY TUBULE ACIDOSIS; KIDNEY TUBULE DISORDER; KYPHOSIS; MALE; NUTRITIONAL SUPPORT; PATIENT MONITORING; PENIS ERECTION; SIDE EFFECT; SKELETON MALFORMATION; VITAMIN D RESISTANT RICKETS;

EID: 13444305363     PISSN: 14750708     EISSN: None     Source Type: Journal    
DOI: 10.1586/14750708.2.1.91     Document Type: Article

References (14)

1. Lemman J, Adams ND, Wilz DR, Brenes LG. Acid and mineral balances and bone in familial proximal renal tubular acidosis. Kidney Int. 58(3), 1267-1277 (2000).
2. Garin KH, Scott DL. Indoetacin in the treatment of proximal tubular acidosis. Clin. Pediatr. 24(12), 711-713 (1985).
3. Shiora M, Igarashi T, Mori T, Komiyama A. Genetic and long term data on a patient with permanent isolated renal tubular acidosis. Eur. J. Pediatr. 159(12), 892-894 (2000).
4. Makitie O, Doria A, Kooh SW, Cole WG, Daneman Asochet E. Early treatment Improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin. Endocrinol. Metab. 88(8), 3591-3597 (2003).
5. Choi IH, Kim JK, Chung CY et al. Deformity correction of knee and leg Lengthening in hypophosphatemic rickets. outcomes and significance of serum phosphate level. J. Pediatr. Orthop. 22(5), 626-631 (2002).
6. Laurence DR, Berrnet PN. Pituitary and sex hormones contraception, ergot. Prostaglandin. In: Clinical Pharmacology Fifth Edition, Laurence DR, Bennett PN (Eds) 759-792 (1980).
7. Laurence DR, Bennett PN. General Pharmacology In: Clinical Pharmacology Fifth Edition, Laurence DR, Bennett H PN (Eds) 104-169 (1980).
8. Silver HK, Peterson RG, Rumack BH. Drug Therapy. In: Current Pediatric Diagnosis & Treatment Ninth Edition, Kempe CH, Silver HK, O'Brien D, Fulginiti VA (Eds) Appleton & Lang, CT, USA, 1093-1105 (1987).
9. Papadimitrou A, Wacharasindhu S, Pearl K, Preece MA, Stanhope R. Treatment of consitiutional delay in prepuberal boys with a prolonged course of low dose oxandrolone. Arch. Dis. Child. 66, 841-1121 (1991).
10. Jones RW, El Bishti MM, Bloom SR et al. The effects of anabolic steroids on growth, body composition and metabolism in boys with chronic renal failure on regular hemodialysis. J. Pediatr. 97, 559-566 (1980).
11. Scriver CR, Tenenhouse HS, Glorieux FH. X-Linked hypophosphatemia: an appreciation of a classic paper and a survey of progress since 1958. Medicine 70, 218-228 (1991).
12. Balsan S, Tieder M. Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height. J. Pediatr. 116, 365-371 (1990).
13. Rasmussen H, Pechet M, Anast C, Mazur A, Gertner J, Broadus A. Long term treatment of familial hypophosphatemic rickets with oral phosphate and 1α-hydroxyvitamin D3. J. Pediatr. 99, 16-25 (1981).
14. Insley J, Wood BA. Pediatric Vade Mecum Tenth Edition, Lloyd-Luke Ltd, London, UK. 16 (1982).